Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

Illumina, Inc.

The latest announcement is out from Illumina ( ($ILMN) ). On August 13, 2026, Illumina, Inc. entered into a credit agreement with a syndicate of le...

Illumina Secures New Syndicated Credit Facility Agreement

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)...

Analysts Are Bullish on Top Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Surgery Partners (SGRY)

Insiders have been trading these 5 stocks: (($BSX)), (($CRCL)), (($ILMN)), (($SO)) and (($TM)). Here is a breakdown of their recent trades and thei...

Boston Scientific, Circle, Illumina, Southern Co, Toyota Insider Frenzy

Illumina ( ($ILMN) ) has shared an update. On August 21, 2025, Illumina entered into a Release Agreement with Icahn-affiliated plaintiffs and forme...

Illumina Seeks Court Approval of GRAIL Settlement

In a report released yesterday, Dan Leonard from RBC Capital maintained a Buy rating on Illumina, with a price target of $230.00. The company’s sha...

RBC Capital Keeps Their Buy Rating on Illumina (ILMN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Illumina (ILMN), Dyne Therapeutics (DYN) and Brist...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (ILMN), Dyne Therapeutics (DYN) and Bristol-Myers Squibb (BMY)

TD Cowen analyst Daniel Brennan maintained a Hold rating on Illumina today and set a price target of $210.00. According to TipRanks, Brennan is a 5...

TD Cowen Keeps Their Hold Rating on Illumina (ILMN)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alignment Healthcare (ALHC), Illumina (ILMN) and S...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (ALHC), Illumina (ILMN) and Siemens Healthineers AG (OtherSEMHF)

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ILMN	$190.96	-1.13%	195.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ILMN	$190.96	-1.1%	195.47K
3
4
5
6

ILMN

Get Illumina, Inc. Data in Excel

Get Illumina, Inc. Data in Excel